Arthritis-drug ads won't name product
Article Abstract:
Monsanto Co.'s G.D. Searle pharmaceuticals unit is launching a television ad campaign for its hot-selling new arthritis drug Celebrex that will not name the product. This is due to regulations that require the company to mention any potential side effects if the product is actually mentioned. By not naming the drug, Searle is able to sidestep having to inform viewers about the potential for existing arthritis-pain drugs to cause potentially fatal bleeding ulcers in about one percent of chronic users each year. Celebrex became the fastest-selling pharmaceutical product since companies began monitoring this data, but sales have fallen off recently after news reports about some ulcers occurring in a handful of patients taking the drug. The campaign, created by the Leo Burnett agency, will focus on arthritis pain and provide an 800 number that viewers can call to receive information. Another campaign that will mention Celebrex specifically is planned for later this year.
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Cargill searches for a corporate identity
Article Abstract:
Cargill Inc. hired Martin/Williams Advertising agency to work on its first big corporate identity campaign. Martin/Williams plans to launch Cargill's television and print ads early next year across North America. Cargill may be the largest company Americans know the least about, even though its businesses handle much of what ends up on their plates each day. Based on the North American campaign, Cargill will decide whether to take the image campaign international where it has around 40% of its facilities.
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Monsanto brings 'Genetic' ads to Europe
Article Abstract:
Monsanto is spending about $5 million on advertisements in British and French newspapers to promote genetic engineering for crops. The purpose of the campaign is to persuade leary Europeans that genetic engineering for crops is beneficial. Supermarket executives are happy that Monsanto is taking some of the heat from worried consumers. Antibiotech activists, including the Prince of Whales, are upset by the ads. Some of Monsanto's contemporaries are worried the ads will grate on the suspicious public.
Comment:
Spends $5 million to promote genetic engineering for crops
Publication Name: The Wall Street Journal Western Edition
Subject: Business, general
ISSN: 0193-2241
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: British Air's new no-frills carrier, Go, to battle its discount rivals. AMR-British air linkup just keeps circling, circling
- Abstracts: Intel files suit against Intergraph, launches counterattack against FTC. Intel appeals judge's ruling on Intergraph
- Abstracts: FTC orders Novartis ads to correct claim. NHTSA creates a class for electric vehicles
- Abstracts: U.S. report on Net commerce set for release; key recommendations stress self-regulation
- Abstracts: NextWave sues FCC over licenses won in bidding. Sales of Apple's iMac Blossom, retailers say. Cisco, Pirelli explore pact for fiber gear